| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President | President | Director
3 companies
Ryan Charles S. is a President at Quince Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $146K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 | QNCX Quince Therapeutics, Inc. | President | Buy | 48,387 | $0.65 | $31,451.55 | +65.3% | +186.9% | +167.2% | |
| Dec 7, 2015 | BRTX Biorestorative Therapies, Inc. | Director | Buy | 6,250 | $4.00 | $25,000.00 | +62.5% | - | - | |
| May 8, 2015 | BRTX Biorestorative Therapies, Inc. | Director | Buy | 200,000 | $0.25 | $50,000.00 | New | - | - |